Cargando…
P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428996/ http://dx.doi.org/10.1097/01.HS9.0000849816.07364.24 |
| _version_ | 1784779294233329664 |
|---|---|
| author | Shah, N. Ayers, D. Cope, S. Karampampa, K. Towle, K. Braverman, J. Mojebi, A. Caisip, C. Dhanda, D. |
| author_facet | Shah, N. Ayers, D. Cope, S. Karampampa, K. Towle, K. Braverman, J. Mojebi, A. Caisip, C. Dhanda, D. |
| author_sort | Shah, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428996 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289962022-08-31 P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY Shah, N. Ayers, D. Cope, S. Karampampa, K. Towle, K. Braverman, J. Mojebi, A. Caisip, C. Dhanda, D. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428996/ http://dx.doi.org/10.1097/01.HS9.0000849816.07364.24 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Shah, N. Ayers, D. Cope, S. Karampampa, K. Towle, K. Braverman, J. Mojebi, A. Caisip, C. Dhanda, D. P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_full | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_fullStr | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_full_unstemmed | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_short | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_sort | p1740: health-related quality of life in patients with relapsed/refractory multiple myeloma (rrmm) treated with idecabtagene vicleucel vs belantamab mafodotin: a matching-adjusted indirect comparison study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428996/ http://dx.doi.org/10.1097/01.HS9.0000849816.07364.24 |
| work_keys_str_mv | AT shahn p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT ayersd p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT copes p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT karampampak p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT towlek p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT bravermanj p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT mojebia p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT caisipc p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT dhandad p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy |